167 related articles for article (PubMed ID: 15479843)
1. Further investigation of simian immunodeficiency virus Vif function in human cells.
Gaddis NC; Sheehy AM; Ahmad KM; Swanson CM; Bishop KN; Beer BE; Marx PA; Gao F; Bibollet-Ruche F; Hahn BH; Malim MH
J Virol; 2004 Nov; 78(21):12041-6. PubMed ID: 15479843
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.
Ribeiro AC; Maia e Silva A; Santa-Marta M; Pombo A; Moniz-Pereira J; Goncalves J; Barahona I
J Virol; 2005 Jan; 79(2):823-33. PubMed ID: 15613310
[TBL] [Abstract][Full Text] [Related]
3. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
[TBL] [Abstract][Full Text] [Related]
4. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.
Cantin R; Méthot S; Tremblay MJ
J Virol; 2005 Jun; 79(11):6577-87. PubMed ID: 15890896
[No Abstract] [Full Text] [Related]
5. APOBEC3G genetic variants and their influence on the progression to AIDS.
An P; Bleiber G; Duggal P; Nelson G; May M; Mangeat B; Alobwede I; Trono D; Vlahov D; Donfield S; Goedert JJ; Phair J; Buchbinder S; O'Brien SJ; Telenti A; Winkler CA
J Virol; 2004 Oct; 78(20):11070-6. PubMed ID: 15452227
[TBL] [Abstract][Full Text] [Related]
6. Controlling lentiviruses: single amino acid changes can determine specificity.
Kaiser SM; Emerman M
Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3725-6. PubMed ID: 15010528
[No Abstract] [Full Text] [Related]
7. The HIV-1 Vif protein: a paradigm for viral:cell interactions.
Pomerantz RJ
Cell Mol Life Sci; 2003 Oct; 60(10):2017-9. PubMed ID: 14618252
[No Abstract] [Full Text] [Related]
8. Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans.
Tebit DM; Nickel G; Gibson R; Rodriguez M; Hathaway NJ; Bain K; Reyes-Rodriguez AL; Ondoa P; Heeney JL; Li Y; Bongorno J; Canaday D; McDonald D; Bailey JA; Arts EJ
EBioMedicine; 2024 Feb; 100():104965. PubMed ID: 38215691
[TBL] [Abstract][Full Text] [Related]
9. The DEAD box RNA helicase DDX42 is an intrinsic inhibitor of positive-strand RNA viruses.
Bonaventure B; Rebendenne A; Chaves Valadão AL; Arnaud-Arnould M; Gracias S; Garcia de Gracia F; McKellar J; Labaronne E; Tauziet M; Vivet-Boudou V; Bernard E; Briant L; Gros N; Djilli W; Courgnaud V; Parrinello H; Rialle S; Blaise M; Lacroix L; Lavigne M; Paillart JC; Ricci EP; Schulz R; Jouvenet N; Moncorgé O; Goujon C
EMBO Rep; 2022 Nov; 23(11):e54061. PubMed ID: 36161446
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4
Bauby H; Ward CC; Hugh-White R; Swanson CM; Schulz R; Goujon C; Malim MH
mBio; 2021 Jun; 12(3):e0136921. PubMed ID: 34154423
[TBL] [Abstract][Full Text] [Related]
11. Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest.
Salamango DJ; Harris RS
Front Microbiol; 2020; 11():622012. PubMed ID: 33510734
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy Applications of Non-Human Lentiviral Vectors.
Munis AM
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003635
[TBL] [Abstract][Full Text] [Related]
13. CAEV Vif Hijacks ElonginB/C, CYPA and Cullin5 to Assemble the E3 Ubiquitin Ligase Complex Stepwise to Degrade oaA3Z2-Z3.
Zhao Z; Li Z; Huan C; Wang H; Su X; Zhang W
Front Microbiol; 2019; 10():565. PubMed ID: 30941116
[TBL] [Abstract][Full Text] [Related]
14. Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.
Sato K; Misawa N; Takeuchi JS; Kobayashi T; Izumi T; Aso H; Nagaoka S; Yamamoto K; Kimura I; Konno Y; Nakano Y; Koyanagi Y
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212937
[TBL] [Abstract][Full Text] [Related]
15. Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.
Mack K; Starz K; Sauter D; Langer S; Bibollet-Ruche F; Learn GH; Stürzel CM; Leoz M; Plantier JC; Geyer M; Hahn BH; Kirchhoff F
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077643
[TBL] [Abstract][Full Text] [Related]
16. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.
Smith JL; Izumi T; Borbet TC; Hagedorn AN; Pathak VK
J Virol; 2014 Sep; 88(17):9893-908. PubMed ID: 24942576
[TBL] [Abstract][Full Text] [Related]
18. Replication potentials of HIV-1/HSIV in PBMCs from northern pig-tailed macaque (Macaca leonina).
Lei AH; Zhang GH; Tian RR; Zhu JW; Zheng HY; Pang W; Zheng YT
Dongwuxue Yanjiu; 2014 May; 35(3):186-95. PubMed ID: 24866489
[TBL] [Abstract][Full Text] [Related]
19. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
Yoshida T; Koyanagi Y; Strebel K
J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
[TBL] [Abstract][Full Text] [Related]
20. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Goujon C; Moncorgé O; Bauby H; Doyle T; Ward CC; Schaller T; Hué S; Barclay WS; Schulz R; Malim MH
Nature; 2013 Oct; 502(7472):559-62. PubMed ID: 24048477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
